Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD+) synthesis, and Sirt1, an NAD+-dependent histone deacetylase, protect the heart against ischemia/reperfusion (I/R). It remains unknown whether Nampt mediates the protective effect of ischemic preconditioning (IPC), whether nicotinamide mononucleotide (NMN, 500 mg/kg), a product of Nampt in the NAD+ salvage pathway, mimics the effect of IPC, or whether caloric restriction (CR) upregulates Nampt and protects the heart through a Sirt1-dependent mechanism. IPC upregulated Nampt protein, and the protective effect of IPC against ischemia (30 minutes) and reperfusion (24 hours) was attenuated at both early and late phases in Nampt +/- mice, suggesting that Nampt plays an essential role in mediating the protective effect of IPC. In order to mimic the effect of Nampt, NMN was administered by intraperitoneal injection. NMN significantly increased the level of NAD+ in the heart at baseline and prevented a decrease in NAD+ during ischemia. NMN protected the heart from I/R injury when it was applied once 30 minutes before ischemia or 4 times just before and during reperfusion, suggesting that exogenous NMN protects the heart from I/R injury in both ischemic and reperfusion phases. The protective effect of NMN was accompanied by decreases in acetylation of FoxO1, but it was not obvious in Sirt1 KO mice, suggesting that the effect of NMN is mediated through activation of Sirt1. Compared to control diet (90% calories), CR (60% calories for 6 weeks) in mice led to a significant reduction in I/R injury, accompanied by upregulation of Nampt. The protective effect of CR against I/R injury was not significant in cardiac-specific Sirt1 KO mice, suggesting that the protective effect of CR is in part mediated through the Nampt-Sirt1 pathway. In conclusion, exogenous application of NMN and CR protects the heart by both mimicking IPC and activating Sirt1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, they have demonstrated beneficial pharmacological activities in acute renal failure [28], anti-inflammatory [29–31], cardio and vasoprotective actions [32–35], telomere lengthening [36, 37•], extend lifespan and promote health in various organisms, from yeasts to mammals [10, 14, 15, 38].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed Central · Cited by 4,150
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510 · cited 1×
“Since the deacetylase activity of Sirt1 critically depends upon the intracellular level of nicotinamide adenine dinucleotide (NAD) [10], NAD may be an alternative target for promoting IPC through Sirt1.”
BackgroundMatsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000261924.76669.36 · Cited by 1,505 · cited 12×
“ATP Assays Primary cultured myocytes were plated on 12 well dishes with 1 ml/well myocyte medium (BrdU (+)).”
BackgroundSelf-citationSirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147 · cited 2×
“sufficient to protect the heart from oxidative stress [9] and I/R”
BackgroundSelf-citationCircadian Clock Feedback Cycle Through NAMPT-Mediated NAD + Biosynthesis
Ramsey, K. M., Yoshino, J., Brace, C. S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.-K., Chong, J. L., Buhr, E. D., Lee, C., et al. (2009) · Science · doi:10.1126/science.1171641 · Cited by 1,126 · cited 1×
“Expression of Nampt is also regulated by CLOCK:BMAL1, the key genes in the circadian mechanism [29].”
BackgroundNampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911 · cited 1×
“Interestingly, NMN, the product of the ratelimiting enzyme in the NAD salvage pathway, has been used previously in order to achieve the same effect as overexpression of Nampt, where the administration of NMN caused a partial recovery of insulin secretion from pancreatic b-cells [14] in Nampt +/2 mice.”
MethodFulco, M., Cen, Y., Zhao, P., Hoffman, E. P., McBurney, M. W., Sauve, A. A., & Sartorelli, V. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.02.004 · Cited by 820 · cited 1×
“Nampt is regulated by HIF1a [25], FoxO [26], and LXR [27] transcription factors, as well as through an AMPK-dependent mechanism [28].”
BackgroundHariharan, N., Maejima, Y., Nakae, J., Paik, J., DePinho, R. A., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.110.227371 · Cited by 692 · cited 2×
“This is consistent with our previous observations that both Nampt and Sirt1 promote autophagy in cardiomyocytes [13,16].”
MethodResultSelf-citationSilent Information Regulator 1 Protects the Heart From Ischemia/Reperfusion
Hsu, C.-P., Zhai, P., Yamamoto, T., Maejima, Y., Matsushima, S., Hariharan, N., Shao, D., Takagi, H., Oka, S., & Sadoshima, J. (2010) · Circulation · doi:10.1161/circulationaha.110.958033 · Cited by 560 · cited 5×
“injury through deacetylation of FoxO transcription factors [8].”
BackgroundResultSelf-citation
Cited by
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
“…administration inhibits acute renal injury in a SIRT1-dependent manner (Guan et al., 2017), heart failure (Karamanlidis et al., 2013; Lee et al., 2016; Martin et al., 2017; Yamamoto et al., 2014), and radiation-induced DNA damage (Li et al., 2017), further demonstrating pleiotropic benefits of NMN.”
InfluentialMitochondrial dysfunction in pathophysiology of heart failure
Zhou, B., & Tian, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120849 · Cited by 923
“Using pharmacological or genetic approaches to target NAD+ salvage pathway, these studies found that increasing intracellular NAD+ level enhanced mitochondrial stress tolerance, improved myocardial energetics, reduced the contractile dysfunction caused by pressure overload or adrenergic stimulation, and improved cardi…”
BackgroundMills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930
“In addition to the already reported effects of short-term NMN administration on various pathological conditions (Caton et al., 2011; Gomes et al., 2013; Long et al., 2015; Stein and Imai, 2014; Yamamoto et al., 2014; Yoshino et al., 2011), this pleiotropic effect of long-term NMN administration opens a new avenue to d…”
InfluentialTherapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
NAD+ homeostasis in health and disease
Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627
Metabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501
“IL-10 expression upon ETC interference in myeloid cells can be rescued with the NAD precursor nicotinamide mononucleotide [156], which has been found to be cardioprotective in an ischemia and reperfusion model [157].”
BackgroundSirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases
Kane, A. E., & Sinclair, D. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312498 · Cited by 487
Zhang, S., Weinberg, S., DeBerge, M., Gainullina, A., Schipma, M., Kinchen, J. M., Ben-Sahra, I., Gius, D. R., Yvan-Charvet, L., Chandel, N. S., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.004 · Cited by 485
“To test this, we added NAD+ precursor NMN to Rispfl/fl LysMcre macrophages during efferocytosis and found that NMN was sufficient to rescue IL-10 production (Figure 5D).”
BackgroundInfluentialMitochondrial ROS in myocardial ischemia reperfusion and remodeling
Bugger, H., & Pfeil, K. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165768 · Cited by 460
Protective effects of sirtuins in cardiovascular diseases: from bench to bedside
Winnik, S., Auwerx, J., Sinclair, D. A., & Matter, C. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv290 · Cited by 422
Aging and Autophagy in the Heart
Shirakabe, A., Ikeda, Y., Sciarretta, S., Zablocki, D. K., & Sadoshima, J. (2016) · Circulation Research · doi:10.1161/circresaha.116.307474 · Cited by 441
“cellular proteins, including FoxO, in the heart, which, in turn, protects the heart from ischemia/reperfusion injury.(158) This suggests that supplementation of NAD via its precursors,”
Self-citationSIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection
D'Onofrio, N., Servillo, L., & Balestrieri, M. L. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7178 · Cited by 388
“Furthermore, exogenous application of nicotinamide mononucleotide protects heart from I/R by mimicking the cardioprotective effect of ischemic preconditioning and overexpression of NAMPT, thereby protecting through an SIRT1-dependent mechanism (202).”
BackgroundThe role of sirtuins in cardiac disease
Matsushima, S., & Sadoshima, J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00053.2015 · Cited by 375
Self-citationNRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Ratajczak, J., Joffraud, M., Trammell, S. A. J., Ras, R., Canela, N., Boutant, M., Kulkarni, S. S., Rodrigues, M., Redpath, P., Migaud, M. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms13103 · Cited by 378
Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
Diguet, N., Trammell, S. A. J., Tannous, C., Deloux, R., Piquereau, J., Mougenot, N., Gouge, A., Gressette, M., Manoury, B., Blanc, J., et al. (2018) · Circulation · doi:10.1161/circulationaha.116.026099 · Cited by 358
Sirtuins Link Inflammation and Metabolism
Vachharajani, V. T., Liu, T., Wang, X., Hoth, J. J., Yoza, B. K., & McCall, C. E. (2016) · Journal of Immunology Research · doi:10.1155/2016/8167273 · Cited by 320
“Cardiovascular protective benefits of caloric restriction support SIRT1’s ability to promote lipolysis, improve insulin sensitivity, and limit proinflammatory macrophage activity [52, 54].”
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
Bonora, M., Wieckowski, M. R., Sinclair, D. A., Kroemer, G., Pinton, P., & Galluzzi, L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0074-0 · Cited by 294
NAD+ homeostasis in renal health and disease
Ralto, K. M., Rhee, E. P., & Parikh, S. M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0216-6 · Cited by 291
Slc12a8 is a nicotinamide mononucleotide transporter
Grozio, A., Mills, K. F., Yoshino, J., Bruzzone, S., Sociali, G., Tokizane, K., Lei, H. C., Cunningham, R., Sasaki, Y., Migaud, M. E., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0009-4 · Cited by 287
NAD + Metabolism in Cardiac Health, Aging, and Disease
Abdellatif, M., Sedej, S., & Kroemer, G. (2021) · Circulation · doi:10.1161/circulationaha.121.056589 · Cited by 255
Airhart, S. E., Shireman, L. M., Risler, L. J., Anderson, G. D., Nagana Gowda, G. A., Raftery, D., Tian, R., Shen, D. D., & O’Brien, K. D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186459 · Cited by 259
Pleiotropic effects of mitochondria in aging
Lima, T., Li, T. Y., Mottis, A., & Auwerx, J. (2022) · Nature Aging · doi:10.1038/s43587-022-00191-2 · Cited by 236
Cardiac metabolism as a driver and therapeutic target of myocardial infarction
Zuurbier, C. J., Bertrand, L., Beauloye, C. R., Andreadou, I., Ruiz‐Meana, M., Jespersen, N. R., Kula‐Alwar, D., Prag, H. A., Eric Botker, H., Dambrova, M., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15180 · Cited by 236
NAD + Repletion Reverses Heart Failure With Preserved Ejection Fraction
Tong, D., Schiattarella, G. G., Jiang, N., Altamirano, F., Szweda, P. A., Elnwasany, A., Lee, D. I., Yoo, H., Kass, D. A., Szweda, L. I., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317046 · Cited by 239
Sirtuin regulation in aging and injury
Poulose, N., & Raju, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.017 · Cited by 236
Modulating NAD + metabolism, from bench to bedside
Katsyuba, E., & Auwerx, J. (2017) · The EMBO Journal · doi:10.15252/embj.201797135 · Cited by 221
“NMN administration protected the mice from ischemic injury via the recovery of cardiac NAD + content and subsequent SIRT1 activation (Yamamoto et al , 2014).”
The human NAD metabolome: Functions, metabolism and compartmentalization
Nikiforov, A., Kulikova, V., & Ziegler, M. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1028612 · Cited by 215
“health benefits from NMN supplementation (e.g. by injection into mice; Revollo et al., 2007; Yamamoto et al., 2014; Yoshino et al., 2011).”
BackgroundRole of NAD+ and mitochondrial sirtuins in cardiac and renal diseases
Hershberger, K. A., Martin, A. S., & Hirschey, M. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.5 · Cited by 218
Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns
Nadeeshani, H., Li, J., Ying, T., Zhang, B., & Lu, J. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.08.003 · Cited by 208
“NMN is a precursor of NAD that acts as an intermediate in NAD biosynthesis, while dietary supplements of NMN are found to increase the NAD levels in the body [5].”
BackgroundLong, A. N., Owens, K., Schlappal, A. E., Kristian, T., Fishman, P. S., & Schuh, R. A. (2015) · BMC Neurology · doi:10.1186/s12883-015-0272-x · Cited by 196
“The enzyme NMN adenyltransferase (NMNAT) converts NMN to NAD in one step [4,9,10] making NMN a key precursor with possible therapeutic implications for increased NAD levels [11,12].”
BackgroundInfluentialHong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 174
Myocardial stress and autophagy: mechanisms and potential therapies
Delbridge, L. M. D., Mellor, K. M., Taylor, D. J., & Gottlieb, R. A. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.35 · Cited by 178
Ferdinandy, P., Andreadou, I., Baxter, G. F., Bøtker, H. E., Davidson, S. M., Dobrev, D., Gersh, B. J., Heusch, G., Lecour, S., Ruiz-Meana, M., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000348 · Cited by 159
Francisco, J. J., & Re, D. P. D. (2023) · Antioxidants · doi:10.3390/antiox12111944 · Cited by 191
Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond
Sun, Q., Karwi, Q. G., Wong, N. K. P., & Lopaschuk, G. D. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae231 · Cited by 191
Histone acetylation and DNA methylation in ischemia/reperfusion injury
Tang, J., & Zhuang, S. (2019) · Clinical Science · doi:10.1042/cs20180465 · Cited by 152
Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease
Yao, Z., Yang, W., Gao, Z., & Jia, P. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.027 · Cited by 140
“The salvage pathway (primary route) way is to use nicotinamide, nicotinic acid, nicotinamide riboside, or the de novo pathway with tryptophan [11].”
Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes
Fukushima, A., & Lopaschuk, G. D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.020 · Cited by 153
Mitochondrial Mechanisms in Diabetic Cardiomyopathy
Gollmer, J., Zirlik, A., & Bugger, H. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0185 · Cited by 144
Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
Poddar, S. K., Sifat, A. E., Haque, S., Nahid, N. A., Chowdhury, S., & Mehedi, I. (2019) · Biomolecules · doi:10.3390/biom9010034 · Cited by 136
“This biomolecule has demonstrated numerous beneficial pharmacological activities in several preclinical disease models including myocardial and cerebral ischemia, neurodegenerative disorders like Alzheimer’s disease, and diabetes [6,7,27].”
BackgroundMartin, A. S., Abraham, D. M., Hershberger, K. A., Bhatt, D. P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M. J., Grimsrud, P. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93885 · Cited by 128
“In these models, NAD+ precursor supplementation attenuates cardiomyopathy in mitochondrial complex I deficiency (6), extends lifespan in mice with cardiac iron deficiency from genetic ablation of transferrin receptor (7), protects against ischemia-reperfusion (I/R) injury induced ROS formation (8), and blunts develop-”
BackgroundAging: Molecular Pathways and Implications on the Cardiovascular System
de Almeida, A. J. P. O., Ribeiro, T. P., & de Medeiros, I. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7941563 · Cited by 129
“SIRT1 activation induced by CR improves heart protection from ischemia/reperfusion, and this effect is abolished in SIRT1 knockout mice [161].”
BackgroundRegulation of NAD+ metabolism in aging and disease
Chu, X., & Raju, R. P. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154923 · Cited by 116
Alegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
Type 2 diabetes – An autoinflammatory disease driven by metabolic stress
Gonzalez, L. L., Garrie, K., & Turner, M. D. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.034 · Cited by 110
Imai, S.-I. (2016) · npj Systems Biology and Applications · doi:10.1038/npjsba.2016.18 · Cited by 96
Miyamoto, S. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0286-9 · Cited by 105
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
Braidy, N., & Liu, Y. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110831 · Cited by 103
Fukushima, A., & Lopaschuk, G. D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.020 · Cited by 103
Therapeutic potential of boosting NAD+ in aging and age-related diseases
Aman, Y., Qiu, Y., Tao, J., & Fang, E. F. (2018) · Translational Medicine of Aging · doi:10.1016/j.tma.2018.08.003 · Cited by 82
New and revisited approaches to preserving the reperfused myocardium
Kloner, R. A., Brown, D. A., CSETE, M. E., Dai, W., Downey, J. M., Gottlieb, R. A., Hale, S. L., & Shi, J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.102 · Cited by 87
Mitochondrial quality control in health and cardiovascular diseases
Atici, A. E., Crother, T. R., & Rivas, M. N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1290046 · Cited by 93
The Oxygen Paradox, the French Paradox, and age-related diseases
Davies, J. M. S., Cillard, J., Friguet, B., Cadenas, E., Cadet, J., Cayce, R., Fishmann, A., Liao, D., Bulteau, A.-L., Derbré, F., et al. (2017) · GeroScience · doi:10.1007/s11357-017-0002-y · Cited by 82
Mateuszuk, Ł., Campagna, R., Kutryb-Zając, B., Kuś, K., Słominska, E. M., Smolenski, R. T., & Chlopicki, S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114019 · Cited by 81
Mitochondria and ischemia reperfusion injury
Panconesi, R., Widmer, J. D., Carvalho, M. F., Eden, J., Dondossola, D. E., Dutkowski, P., & Schlegel, A. A. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001015 · Cited by 89
Tannous, C., Booz, G. W., Altara, R., Muhieddine, D. H., Mericskay, M., Refaat, M. M., & Zouein, F. A. (2020) · Acta Physiologica · doi:10.1111/apha.13551 · Cited by 84
Molecular properties and regulation of NAD+ kinase (NADK)
Oka, S., Titus, A. S., Zablocki, D., & Sadoshima, J. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102561 · Cited by 86
Self-citation才原一浩, Kamikubo, R., Ikemoto, K., Uchida, K., & Akagawa, M. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b01185 · Cited by 89
Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia
Li, F., Fushima, T., Oyanagi, G., Townley-Tilson, H. W. D., Sato, E., Nakada, H., Oe, Y., Hagaman, J. R., Wilder, J., Li, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614947113 · Cited by 82
“Nicotinamide probably ameliorates the consequences of PE-associated ischemia in the same way that it protects the heart from ischemic reperfusion injury (25).”
BackgroundZhou, X., Curbo, S., Li, F., Krishnan, S., & Karlsson, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4443-1 · Cited by 86
NAD+ repletion with niacin counteracts cancer cachexia
Beltrà, M., Pöllänen, N., Fornelli, C., Tonttila, K., Hsu, M. Y., Zampieri, S., Moletta, L., Corrà, S., Porporato, P. E., Kivelä, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37595-6 · Cited by 78
Role of Sirtuins in Regulating Pathophysiology of the Heart
Bindu, S., Pillai, V. B., & Gupta, M. P. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.04.015 · Cited by 78
“An abundant literature is available regarding the role of SIRT1 in CVD. Activation of SIRT1 seems to be a promising strategy in I/R-induced injury.”
InfluentialHosseini, L., Vafaee, M. S., & Badalzadeh, R. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419882002 · Cited by 76
“The previous experimental studies on the cardioprotective effect of therapeutics such as melatonin or NMN or other agents have been carried out on the young healthy animal and focus on very limited aspects of the disease.(14,31) Aging results in structural and functional alterations in heart, leading to myocardial dys…”
BackgroundMethodInfluentialCardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH
Nadtochiy, S. M., Wang, Y. T., Nehrke, K. W., Munger, J., & Brookes, P. S. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.06.007 · Cited by 77
“Sirt1−/− described above [10], hearts from Sirt3−/− mice also exhibited a significantly greater level of IR injury at baseline (infarct 87±3% in Sirt3−/− vs.”
BackgroundInfluentialβ-nicotinamide mononucleotide (NMN) production in Escherichia coli
Marinescu, G. C., Popescu, R.-G., Stoian, G., & Dinischiotu, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-30792-0 · Cited by 69
Zhang, M., & Ying, W. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7445 · Cited by 83
Mericskay, M., Zuurbier, C. J., Heather, L. C., Karlstaedt, A., Inserte, J., Bertrand, L., Kararigas, G., Ruiz‐Meana, M., Maack, C., & Schiattarella, G. G. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01166-7 · Cited by 81
Sims, C. A., Guan, Y., Mukherjee, S., Singh, K., Botolin, P., Davila, A., & Baur, J. A. (2018) · JCI Insight · doi:10.1172/jci.insight.120182 · Cited by 64
“These data suggest that NMN treatment is effective even after injury and lend support to the growing body of literature suggesting that NAD precursors can mitigate ischemia/reperfusion injury (15, 17, 30, 31).”
BackgroundResultFukamizu, Y., Uchida, Y., Shigekawa, A., Sato, T., Kosaka, H., & Sakurai, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-18272-y · Cited by 69
Sirtuins at the Service of Healthy Longevity
Watroba, M., & Szukiewicz, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.724506 · Cited by 64
NAD+-dependent SIRT1 deactivation has a key role on ischemia–reperfusion-induced apoptosis
Cattelan, A. M., Ceolotto, G., Bova, S., Albiero, M., Kuppusamy, M., Martin, S. D., Semplicini, A., Fadini, G. P., de Kreutzenberg, S. V., & Avogaro, A. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.02.004 · Cited by 63
Emerging potential benefits of modulating NAD + metabolism in cardiovascular disease
Matasic, D. S., Brenner, C., & London, B. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00409.2017 · Cited by 66
“These in vitro findings were confirmed in vivo with intraperitoneal injections of NMN before and during ischemia that were protective against I/R injury, as measured by reduced infarct size and increased SIRT1 activity (107).”
Protein Kinase C Epsilon Promotes Cerebral Ischemic Tolerance Via Modulation of Mitochondrial Sirt5
Morris-Blanco, K. C., Dave, K. R., Saul, I., Koronowski, K. B., Stradecki, H. M., & Pérez‐Pinzón, M. A. (2016) · Scientific Reports · doi:10.1038/srep29790 · Cited by 65
“Both Nampt and sirtuins are integral enzymes for IPC-mediated protection 13,27 .”
Huang, H. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.851698 · Cited by 71
“Various preclinical trials demonstrated the diversified pharmacological activities of NMN in cardiac and cerebral ischemia, Alzheimer’s disease, diet-and age-induced type 2 diabetes, and obesity, all of which are linked to the deficiency of NAD (Yoshino et al., 2011; Yamamoto et al., 2014; Long et al., 2015; Fang et a…”
BackgroundXie, W., Zhu, T., Zhou, P., Xu, H., Meng, X., Ding, T., Nan, F., Sun, G., & Sun, X. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7308386 · Cited by 70
NAD(H) in mitochondrial energy transduction: implications for health and disease
Walker, M. A., & Tian, R. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.03.011 · Cited by 68
Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy
Oka, S., Byun, J., Huang, C.-Y., Imai, N., Ralda, G., Zhai, P., Xu, X., Kashyap, S., Warren, J. S., Maschek, J. A., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317943 · Cited by 62
Self-citationSirtuin 3: Emerging therapeutic target for cardiovascular diseases
Cao, M., Zhao, Q., Sun, X., Qian, H., Lyu, S., Chen, R., Xia, H., & Yuan, W. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.005 · Cited by 62
Wu, K., Li, B., Lin, Q., Xu, W., Zuo, W., Li, J., Liu, N., Tu, T., Zhang, B., Xiao, Y., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119299 · Cited by 60
Nikseresht, S., Khodagholi, F., & Ahmadiani, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27055 · Cited by 58
SIRT3 in Cardiac Physiology and Disease
Koentges, C., Bode, C., & Bugger, H. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00038 · Cited by 60
“Reraising NAD+ levels by overexpression of Nampt or by administration of NMN resulted in reduced myocardial infarct size following IR (63, 83).”
BackgroundMitochondrial translation deficiency impairs NAD+‐mediated lysosomal acidification
Yagi, M., Toshima, T., Amamoto, R., Do, Y., Hirai, H., Setoyama, D., Kang, D., & Uchiumi, T. (2021) · The EMBO Journal · doi:10.15252/embj.2020105268 · Cited by 64
“NAD + levels increased in animal hearts by NMN addition led to increased Sirt1 activity and protection against ischemia/reperfusion injury (Yamamoto et al , 2014).”
PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease
Li, J., Lai, M., Zhang, X., Li, Z., Yang, D., Zhao, M., Wang, D., Sun, Z., Ehsan, S., Li, W., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04613-2 · Cited by 69
“To further investigate whether mitophagy deficiency in prion diseases is due to PINK1-parkin pathway impairment, we chose two mitophagy activators, UA [12, 34] and NMN [12, 35, 36], that can activate the PINK1-parkin pathway.”
BackgroundKoentges, C., Cimolai, M. C., Pfeil, K., Wolf, D., Marchini, T., Tarkhnishvili, A., Hoffmann, M. M., Odening, K. E., Diehl, P., Mühlen, C. V. Z., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.008 · Cited by 57
Zhang, Y.-J., Zhang, M., Zhao, X., Shi, K., Ye, M., Tian, J., Guan, S., Ying, W., & Qu, X. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0817-z · Cited by 58
Pro-inflammatory Cytokines in Acute Coronary Syndromes
Mourouzis, K., Oikonomou, E. K., Siasos, G., Tsalamadris, S., Vogiatzi, G., Antonopoulos, A. S., Fountoulakis, P. N., Goliopoulou, A., Papaioannou, S., & Tousoulis, D. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200413082353 · Cited by 60
Calorie restriction attenuates cerebral ischemic injury via increasing SIRT1 synthesis in the rat
Ran, M., Li, Z., Yang, L., Li, T., Zhang, L., & Dong, H. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.043 · Cited by 58
Immunometabolism of Phagocytes and Relationships to Cardiac Repair
Zhang, S., Bories, G. F. P., Lantz, C. W., Emmons, R., Becker, A., Liu, E., Abecassis, M. M., Yvan‐Charvet, L., & Thorp, E. B. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00042 · Cited by 55
“In a therapeutic context, intraperitoneal injection of NAD precursor nicotinamide mononucleotide (NMN) significantly increased NAD+ in heart and protected from I/R injury (78).”
BackgroundNAD+ Deficits in Age-Related Diseases and Cancer
Garrido, A., & Djouder, N. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.06.001 · Cited by 57
Both gain and loss of Nampt function promote pressure overload-induced heart failure
Byun, J., Oka, S., Imai, N., Huang, C.-Y., Ralda, G., Zhai, P., Ikeda, Y., Ikeda, S., & Sadoshima, J. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00222.2019 · Cited by 54
Self-citationShaping of Hepatic Ischemia/Reperfusion Events: The Crucial Role of Mitochondria
Teodoro, J. S., Silva, R., Machado, I. F., Rosello, A. P., Roselló‐Catafau, J., Rolo, A. P., & Palmeira, C. M. (2022) · Cells · doi:10.3390/cells11040688 · Cited by 53
Tao, A., Xu, X., Kvietys, P. R., Kao, R. L. C., Martin, C. M., & Tao, R. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.10.011 · Cited by 52
Role of Oxidative DNA Damage and Repair in Atrial Fibrillation and Ischemic Heart Disease
Hu, L., Wang, Z., Carmone, C., Keijer, J., & Zhang, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083838 · Cited by 57
Wang, Q., Zuurbier, C. J., Huhn, R., Torregroza, C., Hollmann, M. W., Preckel, B., van den Brom, C. E., & Weber, N. C. (2023) · Cells · doi:10.3390/cells12101432 · Cited by 51
“Mechanisms of protection by NMN precursors relate to the activation of sirtuins, glycolysis, and/or autophagy [67,68,70,71].”
BackgroundAutophagy—A key pathway for cardiac health and longevity
Woodall, B. P., & Gustafsson, Å. B. (2018) · Acta Physiologica · doi:10.1111/apha.13074 · Cited by 52
“NAD levels were increased in the hearts of NMN treated animals, leading to increased Sirt1 activity and protection against ischaemia reperfusion injury.(73) Thus, NMN treatment represents a promising way to activate autophagy in the heart and improve cellular health and longevity.”
BackgroundPharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
She, J., Sheng, R., & Qin, Z. (2021) · Aging and Disease · doi:10.14336/ad.2021.0523 · Cited by 53
“Additionally, NMN protects against cardiac ischaemia and ischaemic stroke [121, 122], Therefore, NMN may be a potential drug for the treatment of age-related neurodegenerative diseases.”
BackgroundNicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Bhasin, S., Seals, D. R., Migaud, M. E., Musi, N., & Baur, J. A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad019 · Cited by 55
Afzaal, A., Rehman, K., Kamal, S., & Akash, M. S. H. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23047 · Cited by 50
Liu, J., Zong, Z., Zhang, W., Chen, Y., Wang, X., Shen, J., Yang, C., Liu, X., & Deng, H. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.702107 · Cited by 48
“It has been amply documented that the administration of NMN increases the cellular NAD and alleviated many diseases symptoms (Yoshino et al., 2011; Yamamoto et al., 2014; Guan et al., 2017).”
Background
Metadata
- Authors
- Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., & Sadoshima, J.
- Affiliations
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Sadoshima, Junichi
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-06
- Volume
- 9
- Issue
- 6
- Pages
- e98972
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4048236
- OpenAlex
- W2163282809
- Cited by
- 305
- References
- 29
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 29 · 2023: 32 · 2022: 30 · 2021: 34 · 2020: 34 · 2019: 18 · 2018: 29 · 2017: 20 · 2016: 24 · 2015: 16 · 2014: 1
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fondation Leducq (HL69020, HL67724, AG27211, HL91469, HL102738)
- U.S. Public Health Service (HL91469, AG27211, HL67724, HL69020, HL102738, HL59139)
- National Institute on Aging (P01AG027211, R01AG023039, AG27211)
- National Heart, Lung, and Blood Institute (HL59139, HL91469, R01HL067724, HL69020, HL102738, R01HL102738, R01HL112330, HL-67724, P01HL059139, P01HL069020, R01HL091469)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- nicotinamide mononucleotide, NAD+ salvage pathway, visfatin, SIRT1, ischemia-reperfusion injury, myocardial ischemia, ischemic preconditioning, caloric restriction, cardioprotection, NAD+ depletion
- MeSH terms
- Animals, Cardiotonic Agents, Heart, Male, Myocardial Infarction, NAD, Nicotinamide Mononucleotide, Reperfusion Injury, Up-Regulation, Myocardial Ischemia, Ischemic Preconditioning, Caloric Restriction, Mice, Nicotinamide Phosphoribosyltransferase, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.